Skip to content
GLP-1 Desk
Menu
Dispatch #74

Hers

Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

Visit HersAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$199/mo (starting dose, compounded)
Tirzepatide
$299/mo (starting dose, plus a separate fee, brand-name)
Coverage
All 50 states
Brand-name
Yes

Weigh Hers against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Hers vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100
State access86/100
Molecule range79/100
Onboarding speed74/100
Support responsiveness71/100
Licensing & trust77/100

What the Desk likes

  • Compounded GLP-1 access

Where points come off

  • Limited public information on program details

The Desk's briefing — C+

Best for: Readers who want mainstream telehealth GLP-1 access.

Hers ranks #74 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (24)

Pricing and verification reflect Hers's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Hers's site. Not medical advice; see our disclosure.

← Back to The Desk